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Abstract
Background: Disruption of axonal transport plays a pivotal role in diabetic neuropathy. A sex-dimorphism exists in
the incidence and symptomatology of diabetic neuropathy; however, no studies so far have addressed sex
differences in axonal motor proteins expression in early diabetes as well as the possible involvement of neuroactive
steroids. Interestingly, recent data point to a role for mitochondria in the sexual dimorphism of neurodegenerative
diseases. Mitochondria have a fundamental role in axonal transport by producing the motors’ energy source, ATP.
Moreover, neuroactive steroids can also regulate mitochondrial function.
Methods: Here, we investigated the impact of short-term diabetes in the peripheral nervous system of male and female
rats on key motor proteins important for axonal transport, mitochondrial function, and neuroactive steroids levels.
Results: We show that short-term diabetes alters mRNA levels and axoplasm protein contents of kinesin family member
KIF1A, KIF5B, KIF5A and Myosin Va in male but not in female rats. Similarly, the expression of peroxisome proliferator-
activated receptor γ co-activator-1α, a subunit of the respiratory chain complex IV, ATP levels and the key regulators of
mitochondrial dynamics were affected in males but not in females. Concomitant analysis of neuroactive steroid levels in
sciatic nerve showed an alteration of testosterone, dihydrotestosterone, and allopregnanolone in diabetic males, whereas
no changes were observed in female rats.
Conclusions: These findings suggest that sex-specific decrease in neuroactive steroid levels in male diabetic animals
may cause an alteration in their mitochondrial function that in turn might impact in axonal transport, contributing to the
sex difference observed in diabetic neuropathy.
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Background
Peripheral diabetic neuropathy (PDN) is one of the
most prevalent complications of diabetes [1]. It can
take different forms, the most common of which is the
length-dependent axonal sensorimotor and autonomic
neuropathy. This is associated with structural changes
in the peripheral nerves, degeneration and impaired
regeneration ability due to a dying-back of distal axons.
Hyperglycemia, a key factor in the pathogenesis of
diabetic complications, mediates phenotypic changes in
mitochondria resulting in increased ROS production,
ATP depletion, and altered calcium homeostasis [2]. The
outcome is the exhaustion of the ATP supply for energy
consuming processes in neurons such as axonal trans-
port. This process is fundamental to maintain neuronal
homeostasis, especially in the peripheral nervous system
(PNS) in which long axons constitute a major challenge
for the movement of cargoes. Cargoes are predominantly
transported along microtubules via ATP-dependent motor
proteins. The kinesin superfamily of proteins and cyto-
plasmic dynein are the main microtubule-based motor
proteins [3]. In addition, cargoes can also be transported
bidirectionally for short distances along actin filaments via
myosin motors [4].
Growing evidence indicates that axonal transport is
impaired in diabetes, probably contributing to the devel-
opment of neurological complications and subsequently
diabetic neuropathy [5–9]. However, despite the main
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role of molecular motors in this process, a limited amount
of work has been performed to analyze the effect of
diabetes on local changes in motor proteins in PNS [7, 9].
Moreover, to our knowledge, no studies have been
performed to analyze sex differences in their levels
and expression under diabetic conditions.
There is increasing evidence of sex differences in the
epidemiology and pathophysiology of PDN. Indeed,
males develop neuropathy earlier than females [10] and
PDN is more frequent in men than in women [11, 12].
Also, nerve conduction abnormalities are more frequent
and severe in males than in females [13, 14]. On the
contrary, neuropathic pain and negative sensory symp-
toms are more frequent in female than in male patients
[14]. Sex differences have been also reported in experi-
mental models of PDN. For instance, the paw withdrawal
threshold is reduced more in females than in males [15].
On the contrary, male exhibited greater intraepidermal
nerve fiber density (IENF) loss than females [16].
Neuroactive steroids may be involved in the generation
of sex differences in PDN. Neuroactive steroids are im-
portant physiological regulators of neural function and
their levels are sex dimorphic both in the central and
peripheral nervous system of control animals and also in
nervous pathologies [17]. We previously reported that
diabetes, in an advanced stage of the disease, influences
local levels of neuroactive steroids in the PNS in a sex-
dimorphic way [18]. Interestingly, also, their protective
effects against alterations induced by diabetes show a
sex-dimorphic feature [19, 20].
In this work, we have explored the possible exist-
ence of sex differences in the impact of early diabetes
on the content and distribution of anterograde and
retrograde motor proteins as well as on different me-
diators of the mitochondrial biogenesis and dynamics
in the PNS.
Methods
Animals
Two-month-old male and female Sprague-Dawley rats
(Crl:CD BR, Charles River, Lecco, Italy) were randomly
assigned to control or diabetic groups. Diabetes was in-
duced by a single intravenous injection of freshly pre-
pared streptozotocin (60 mg/kg; Sigma, Italy) in citrate
buffer 0.09 M pH 4.8 [18]. To determine the different
phases of the estrous cycle, female rats were monitored
by daily vaginal smears and only those demonstrating at
least two consecutive 4-day cycles were used in the
study. One month after the induction of diabetes rats
were weighed, deeply anesthetized with isoflurane and
sacrificed. Females were sacrificed on diestrus day. Sci-
atic nerve and dorsal root ganglia (DRG) were collected
for biochemical analysis.
Preparation of total DRG extract
After dissection, the DRG from each rat was homogenized
in lysis buffer (PBS, pH 7.4, added with 1% Nonidet P-40)
supplemented with protease and phosphatase inhibitor
cocktails (Roche Diagnostic spa, Monza, Italy) with a
TissueLyser II (Qiagen, Milano, Italy) instrument. The
resulting homogenate was sonicated (17 kHz, 10 s each)
and then centrifuged at 1200 g at 4 °C for 10 min. The
supernatant was stored at − 80 °C until use.
Axoplasm extraction
Axoplasm from rat sciatic nerve was extracted according
to the method of Rishal and collaborators [21]. Briefly,
after dissection, the epineurium was removed from the
sciatic nerve and fascicles were then separated by mechan-
ical dissociation with fine forceps. Fascicles were then incu-
bated for 2 h in PBS × 0.2 with protease and phosphatase
inhibitors at room temperature (RT). After three washes in
the same buffer, axoplasm was extracted incubating the
fascicles in PBS × 1 with protease and phosphatase inhibi-
tors at RT for 30 min, followed by centrifugation at 10,000g
for 10 min. The supernatant (axoplasm extract) was stored
at − 80 °C until use.
Western blot analysis
Equal amounts of protein were separated on SDS-PAGE
(4–15% gradient gel; Bio-Rad, Milan, Italy), and Western
blot was performed as described previously [22].
Incubation with specific antibodies (Table 1) was per-
formed overnight at 4 °C. After washing for 1 h in PBS
containing 0.1% Tween-20, the membranes were incubated
with the proper secondary antibody for 2 h and visualized
using enhanced chemiluminescence (ECL) method (Bio-
Rad, Milan, Italy) according to the manufacturer’s in-
structions. Chemiluminescent signals were acquired
with a ChemiDoc TM XRS+ system (Bio-Rad, Milan,
Italy) and the digital quantification of immunoreactive
bands was performed using Image Lab TM software
version 3.0 (Bio-Rad, Milan, Italy). Then, concentra-
tion of each target protein was normalized versus
GAPDH. When phosphorylation of DRP1 was mea-
sured, membranes were first probed for the phosphor-
ylated form of the protein, then stripped, and probed
for the total protein.
Quantitative real-time PCR (RT-qPCR)
RNA and DNA from snap-frozen DRG were extracted
using the proper MiniPrep kit (Zymo Research, Irvine, CA,
USA) following manufacturing protocol. RNA and DNA
were quantified by Nano-DropTM 2000 (ThermoFisher
scientific, Milano, Italy). TaqMan quantitative real-time
PCR was performed by CFX96 real-time system (Bio-Rad
Laboratories, Segrate, Italy). RNA samples were run in du-
plicate as multiplexed reactions with a normalizing internal
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control (18 s rRNA) (Life Technologies Monza, Italy).
Mitochondrial DNA (mt-DNA) content was analyzed
assessing mitochondrial cytochrome c oxidase subunit 2
(mt-CoxII) and 36B4 content as mitochondrial and nuclear
encoded genes, respectively. For KIF1A (Rn01427419), the
probe was purchased from Life Technologies (Monza,
Italy). For the other motor proteins, specific TaqMan MGB
probes and primers sequence (Table 2) were purchased
from Eurofins MWG-Operon (Milano, Italy).
Liquid chromatography tandem mass spectrometry
analysis (LC-MS/MS)
Sciatic nerves were extracted and purified as previously de-
scribed [23]. Quantitative analysis for neuroactive steroid
levels was performed on the basis of calibration curves ex-
tracted and analyzed as the tissues samples. Positive atmos-
pheric pressure chemical ionization (APCI+) experiments
were performed using a linear ion trap-mass spectrometer
(LTQ, ThermoElectron Co., San Jose, CA, USA) equipped
with a Surveyor liquid chromatography (LC) Pump Plus
(ThermoElectron Co., San Jose, CA, USA). The analytical
conditions were previously described [24].
DRG from the different experimental groups were
lysed in 250 μl methanol/acetonitrile 1:1 containing
[U-13C6]-Glucose-1 ng/μl (internal standard, Sigma
Aldrich, 389374) by tissue lyser and spun at 20,000 g
for 5 min at 4 °C. Supernatant was then passed through a
regenerated cellulose filter, dried and resuspended in 100 μl
of MeOH for subsequent analysis. Data were obtained on
an API-4000 triple quadrupole mass spectrometer (AB
Sciex) coupled with an HPLC system (Agilent) and CTC
PAL HTS autosampler (PAL System). The identity of ATP
was confirmed using pure standard. Quantification of ATP
was performed with a liquid chromatography/tandem mass
spectrometry (LC-MS/MS) method using a cyano-phase
LUNA column (50 mm × 4.6 mm, 5 μm; Phenomenex).
Methanolic samples were analyzed by 8 min run in negative
ion mode with a multiple reaction monitoring (MRM) tran-
sition. The mobile phases were phase A: 5 mM ammonium
acetate pH 7.00 in water, and phase B: 5 mM ammonium
acetate pH 7.00 in MeOH. The gradients were as follows:
T0 80%A; T4min 0%A; T5min 0%A; T5.1min 80%A and T8min
80%A with a flow rate of 500 μl/min. MultiQuant™ software
(version 3.0.2) was used for data analysis and peak review
of chromatograms. Quantitative evaluation of ATP was per-
formed based on calibration curves with pure standard;
then, data were normalized on protein content assessed by
BCA method.
Statistical analysis
Unpaired Student’s t test was applied to couples of inde-
pendent variables. Data from experiments with more than
two groups were analyzed by two-way analysis of variance
(ANOVA), with sex and disease as two independent vari-
ables, followed by the Bonferroni post hoc test. All analyses
were performed using GraphPad PRISM (version 5).
Table 1 List of primary antibodies
Primary antibody Sample Antibody dilution Source
KIF5A Total Extracts DRG 1:1.000 Proteintech (21186-1-AP)
Isolated Axoplasm 1:500
KIF5B Total Extracts DRG 1:1.000 Proteintech (21632-1-AP)
Isolated Axoplasm 1:500
KIF1A Total Extracts DRG 1:500 Abcam (ab180153)
Isolated Axoplasm 1:200
Myosin Va Total Extracts DRG 1:500 Cell signaling (3402S)
Isolated Axoplasm 1:200
Dynein Total Extracts DRG 1:500 Sigma (D5167)
Isolated Axoplasm 1:200
Mitoprofile total OXPHOS Total Extracts DRG 1:1.000 Abcam (ab10413)
DRP1 Total Extracts DRG 1:500 Cell signaling (14647S)
DRP1-Ser616 Total Extracts DRG 1:500 Signalway Antibody (12749)
OPA1 Total Extracts DRG 1:500 Cell signaling (80471S)
Table 2 Eurofins MWG-Operon primer sequences
Gene Forward Reverse
36B4 GGATGACTACCCAAAATGCTTC TGGTGTTCTTGCCCATCAG
KIF5A AGGTGCTGAATGGACTGATG ACCTCTGACTTGATCTTGCTG
KIF5B GAATCTGTGGACTCCCTTGG GTTTCTCTGTGACTCTGGATCTG
Dync1i1 ACCCCTATGTCTCCCTCTTC CTTCTCCCAAGTTCTGAGTCTG
MyoVa GATAGAAGGAGTGGACGATGC GAGACGCAAACCCAACATTG
PGC-1α TGAGGAATGCACCGTAAATC GTACAGCTCGAAGTCAGTTTC
mt-Cox II ATTGTATTCCTCATCAGCTCCC TGACAGCTGGGAGAATTGTTC
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Results
Table 3 reports body weight and glucose levels. As ex-
pected, both male and female diabetic rats had high
blood glucose at the end of the experiment. On the con-
trary, only male animals had significantly less weight
gain than non-diabetic controls while in female animals,
administration of streptozotocin (STZ) did not signifi-
cantly modify the body weight.
Axonal motor protein expression is altered by diabetes in
a sex-dimorphic way
We analyzed mRNA levels and the protein content of
molecular motors in the DRG homogenates and isolated
axoplasm. This allowed us to evaluate the different dis-
tribution of motor proteins between the cell body com-
partment (DRG) and the axon compartment (axoplasm)
and to avoid confounding results due to the ubiquitous
expression of KIF5B, Dynein and Myosin Va [3, 25, 26].
Short-term diabetes changes KIF5A protein levels in a
sex-dimorphic way
Two-way ANOVA revealed a significant effect of sex
(p < 0.001) on KIF5A mRNA expression in DRG
(Fig. 1a). On the contrary, no significant effects of sex
or diabetic status were observed in DRG protein levels
(Fig. 1b). The analysis of isolated axoplasm revealed a
significant effect of diabetes (two-way ANOVA p < 0.05).
In particular, post hoc analysis indicated that KIF5A pro-
tein levels were significantly decreased in male diabetic
rats compared to control males (p < 0.05) but not in
female animals (Fig. 1c).
Short-term diabetes changes KIF5B mRNA expression and
protein levels in a sex-dimorphic way
Two-way ANOVA analysis showed a very significant
interaction between sex and diabetic status on KIF5B
mRNA expression in DRG (p < 0.001). In agreement
with previous observations obtained in male hippocam-
pus [6, 9], diabetes induced a significant increase of
KIF5B mRNA expression in male DRG (Bonferroni post
hoc analysis, p < 0.01). However, no significant changes
of KIF5B mRNA expression were observed in DRG of
female diabetic rats compared to control (Fig. 2a). No
Table 3 Body weight and glucose levels
Animal Body weight (g) Body weight (g) Blood glucose (mg/dl)
Before STZ injection At sacrifice At sacrifice
M Ctrl 255.4 ± 2.5 405.0 ± 7.8 106 ± 3
M STZ 263.2 ± 4.1 344.0 ± 9.3*** 530 ± 2***
F Ctrl 177.1 ± 2.9 230.1 ± 4.6 102 ± 4
F STZ 184.7 ± 1.8 223.5 ± 7.5 544.4***
Data are expressed as mean ± SEM (n = 6). Analysis by Student’s t test
***p < 0.001 vs. Ctrl
M male, F female, Ctrl control, STZ streptozotocin
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Fig. 1 Effect of short-term diabetes on KIF5A. a RNA was extracted
from DRG of control (Ctrl) and diabetic (streptozotocin, STZ) male
(M) and female (F) rats. RT-PCR was used to analyze mRNA levels of
KIF5A. b KIF5A protein levels analyzed by immunoblotting in DRG
total extracts of Ctrl and STZ M and F rats. c KIF5A protein levels
analyzed by immunoblotting in isolated axoplasm of Ctrl and STZ M
and F rats. Representative Western blots are presented above the graphs,
with the respective loading controls (GAPDH). The densitometry of each
band was analyzed, and the results are expressed as percentage of M
Ctrl. The columns represent the mean ± SEM, n= 6 animals for each
group. The effects of sex, diabetes, and the interaction sex by
diabetes were analyzed using two-way ANOVA (significance:
#p < 0.05; ###p < 0.001) followed by Bonferroni post hoc test
(significance: *p < 0.05)
Pesaresi et al. Biology of Sex Differences  (2018) 9:6 Page 4 of 14
differences were observed between control or diabetic
males and females, for KIF5B protein levels in DRG ho-
mogenates (Fig. 2b). However, in agreement with previous
observations [6], and similarly to what observed for KIF5A,
Western blot analysis of axoplasm preparation revealed a
significant decrease in KIF5B protein levels (Bonferroni
post hoc analysis, p < 0.05) in male diabetic rats compared
to control males. In contrast, no significant changes were
observed in females (Fig. 2c). Two-way ANOVA analysis
showed no significant effect of sex or diabetic status on
KIF5B protein levels.
Short-term diabetes changes KIF1A mRNA expression and
protein levels in a sex-dimorphic way
Two-way ANOVA analysis revealed a significant effect
of diabetes (p < 0.01) on KIF1A mRNA levels in DRG. In
particular, and in agreement with previous findings [6],
diabetes induced a significant increase of KIF1A mRNA
levels in males (Bonferroni post hoc analysis, p < 0.05).
However, this did not occur in female animals (Fig. 3a).
Nevertheless, no significant changes were detected be-
tween control or diabetic males and females, for the
KIF1A protein levels in DRG (Fig. 3b). The analysis of
isolated axoplasm revealed a significant effect of sex
(two-way ANOVA p < 0.05). In addition, post hoc ana-
lysis indicated that, similarly to what previously observed
by others in axons of hippocampal neuron [6], KIF1A pro-
tein levels were significantly increased in male diabetic
rats compared to control males (p < 0.05). In contrast, no
significant changes were observed in female diabetic rats
compared to control females (Fig. 3c).
Short-term diabetes changes Myosin Va protein levels in
a sex-dimorphic way
Two-way ANOVA showed no significant effect of sex or
diabetic status on Myosin Va mRNA levels as well as
protein levels in DRG (Fig. 4a, b). However, Western blot
analysis of axoplasm preparation revealed a significant
effect of sex (two-way ANOVA p < 0.05) and a significant
interaction between sex and diabetic status (two-way
ANOVA p < 0.05). In addition, post hoc analysis indicated
that Myosin Va levels were significantly higher in the axo-
plasm of diabetic males than in control males (p < 0.05).
As observed for the others motor proteins analyzed, no
significant changes were observed between diabetic and
control female rats (Fig. 4c).
Short-term diabetes does not affect Dynein mRNA
expression and protein levels
In agreement with previous findings in hippocampus [6],
diabetes did not change Dynein mRNA expression and
protein levels in DRG. Two-way ANOVA, however,
showed a significant effect of sex on Dynein mRNA
levels (p < 0.001) (Fig. 5a, b). Western blot analysis of
axoplasm preparation also revealed a significant effect of
sex (two-way ANOVA p < 0.001). No difference was
observed, however, between control or diabetic males
and females for this molecular motor (Fig. 5c).
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Fig. 2 Effect of short-term diabetes on KIF5B. a RNA was extracted
from DRG of control (Ctrl) and diabetic (streptozotocin, STZ) male
(M) and female (F) rats. RT-PCR was used to analyze mRNA levels of
KIF5B. b KIF5B protein levels analyzed by immunoblotting in DRG
total extracts of Ctrl and STZ M and F rats. c KIF5B protein levels analyzed
by immunoblotting in isolated axoplasm of Ctrl and STZ M and F rats.
Representative Western blots are presented above the graphs, with the
respective loading controls (GAPDH). The densitometry of each band
was analyzed and the results are expressed as percentage of M Ctrl. The
columns represent the mean ± SEM, n= 6 animals for each group. The
effects of sex, diabetes, and the interaction sex by diabetes were
analyzed using two-way ANOVA followed by Bonferroni post hoc test
(significance: *p< 0.05; **p< 0.01)
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Fig. 3 Effect of short-term diabetes on KIF1A. a RNA was extracted
from DRG of control (Ctrl) and diabetic (streptozotocin, STZ) male (M)
and female (F) rats. RT-PCR was used to analyze mRNA levels of KIF1A.
b KIF1A protein levels analyzed by immunoblotting in DRG total
extracts of Ctrl and STZ M and F rats. c KIF1A protein levels analyzed
by immunoblotting in isolated axoplasm of Ctrl and STZ M and F rats.
Representative Western blots are presented above the graphs, with the
respective loading controls (GAPDH). The densitometry of each band
was analyzed, and the results are expressed as percentage of M Ctrl.
The columns represent the mean ± SEM, n = 6 animals for each group.
The effects of sex, diabetes, and the interaction sex by diabetes were
analyzed using two-way ANOVA (significance: #p < 0.05; ##p < 0.01)
followed by Bonferroni post hoc test (significance: *p < 0.05)
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Fig. 4 Effect of short-term diabetes on Myosin Va. a RNA was extracted
from DRG of control (Ctrl) and diabetic (streptozotocin, STZ) male (M)
and female (F) rats. RT-PCR was used to analyze mRNA levels of Myosin
Va. b Myosin Va protein levels analyzed by immunoblotting in DRG total
extracts of Ctrl and STZ M and F rats. c Myosin Va protein levels analyzed
by immunoblotting in isolated axoplasm of Ctrl and STZ M and F rats.
Representative Western blots are presented above the graphs, with the
respective loading controls (GAPDH). The densitometry of each band
was analyzed, and the results are expressed as percentage of M Ctrl. The
columns represent the mean ± SEM, n= 6 animals for each group. The
effects of sex, diabetes, and the interaction sex by diabetes were
analyzed using two-way ANOVA (significance: #p< 0.05) followed by
Bonferroni post hoc test (significance: *p< 0.05)
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Mitochondrial biogenesis is altered by diabetes in a sex-
dimorphic way
Following previous studies suggesting that mitochondrial
function and dynamic is impaired in diabetic neuropathy
[2], we examined mitochondrial biogenesis in DRG of
control and diabetic male and female rats.
Short-term diabetes alters PGC-1α gene expression in a
sex-dimorphic way
Real-time PCR analysis of PGC-1α revealed a very signifi-
cant effect of sex (two-way ANOVA p < 0.001) and a very
significant effect of diabetic status (two-way ANOVA
p < 0.01) on PGC-1α mRNA levels. In particular, and
in agreement with the findings of Choi and collabora-
tors [27], 1 month of diabetes induced a significant de-
crease of PGC-1α mRNA levels in males (Bonferroni
post hoc analysis, p < 0.01). On the contrary, diabetic
status did not affect this parameter in female rats (Fig. 6a).
To determine whether the observed decreased expres-
sion of this transcriptional coactivator was associated with
altered mitochondrial biogenesis and function, we mea-
sured the protein content of different subunits of the
respiratory chain complexes (i.e., complex I–II–III–IV)
and the content of mtDNA.
Short-term diabetes alters the expression of respiratory
chain complex IV and total ATP content in a sex-
dimorphic way
As reported in Fig. 6b, quantitative Western blot showed
a significant decrease of respiratory chain complex IV in
DRG of short-term diabetic male rats (Bonferroni post
hoc analysis, p < 0.05). On the contrary, in female ani-
mals, diabetes did not induce a significant change in this
parameter. Two-way ANOVA analysis showed a signifi-
cant interaction between sex and diabetic status on
respiratory chain complex IV expression (p < 0.05). No
significant differences of complex I, II, III, and V were
observed among the four groups (data not shown).
In addition, by LC-MS/MS analysis, we assessed total
ATP levels. The results showed a decrease of ATP levels in
male STZ DRG compared to control animals, while no
changes were observed in female animals [M ctrl (n = 7)
0.37 ± 0.04; M STZ (n = 7) 0.19 ± 0.02 (Bonferroni post hoc
analysis, p < 0.001); F ctrl (n = 7) 0.26 ± 0.03; F STZ (n = 7)
0.24 ± 0.01. Data are expressed as ng/μg of protein ± SEM].
Short-term diabetes does not alter mitochondrial DNA
To determine if a change in mitochondrial DNA (mtDNA)
occurred in DRG of diabetic male and female rats, mtDNA
copy number was measured using quantitative real-time
PCR to obtain a relative ratio of mtDNA over nuclear DNA
(nDNA). The ratio of mtDNA to nDNA was similar in con-
trol male and female rats as well as in diabetic rats (Fig. 6c).
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Fig. 5 Effect of short-term diabetes on Dynein. a RNA was extracted
from DRG of control (Ctrl) and diabetic (streptozotocin, STZ) male
(M) and female (F) rats. RT-PCR was used to analyze mRNA levels of
Dynein. b Dynein protein levels analyzed by immunoblotting in DRG
total extracts of Ctrl and STZ M and F rats. c Dynein protein levels
analyzed by immunoblotting in isolated axoplasm of Ctrl and STZ M and
F rats. Representative Western blots are presented above the graphs,
with the respective loading controls (GAPDH). The densitometry of each
band was analyzed, and the results are expressed as percentage of M
Ctrl. The columns represent the mean ± SEM, n= 6 animals for each
group. The effects of sex, diabetes, and the interaction sex by diabetes
were analyzed using two-way ANOVA (significance: ###p< 0.001)
followed by Bonferroni post hoc test
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Short-term diabetes activates Drp1 activity in a sex-
dimorphic way
To further understand the effect of diabetic status on
mitochondrial dynamics, we examined the expression of
proteins known to regulate mitochondrial fission/fusion
(MFN2, OPA1, DRP1) in DRG of control and diabetic
male and female rats.
First, we assessed whether diabetic status changes DRP1
phosphorylation at serine 616 (DRP1P). This post-
translational modification activates DRP1 and causes
DRP1 to translocate to the mitochondria and form multi-
mers that circumferentially constrict the mitochondrion
and initiate fission [28].
As expected and in line with previous findings [29],
1 month of diabetes did not significantly modify the
protein levels of total DRP1 in either male or female rats
(data not shown).
However, two-way ANOVA analysis showed a signifi-
cant effect of sex on DRP1P. In particular, we detected a
significant increase in the expression of activated DRP1 in
the DRG of diabetic males when compared with control
males (Bonferroni post hoc analysis, p < 0.05) whereas no
significant changes were observed between diabetic and
control female rats (Fig. 7a).
Short-term diabetes alters the expression of Mfn2 in a
sex-dimorphic way
Mitofusin 2 (MFN2) is an outer mitochondrial membrane
protein that regulates mitochondrial fusion and is also a
key component in the regulation of mitochondrial trans-
port [30]. As shown in Fig. 7b, two-way ANOVA revealed
a significant effect of diabetes (p < 0.05) on MFN2 levels.
In particular, post hoc analysis indicated that diabetes
significantly decreased MFN2 protein levels in male rats
(Bonferroni post hoc analysis, p < 0.05). On the contrary,
diabetes did not induce a significant change in this param-
eter in female animals (Fig. 7b).
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respiratory chain complex IV expression and mitochondrial DNA.
a RNA was extracted from DRG of control (Ctrl) and diabetic
(streptozotocin, STZ) male (M) and female (F) rats. RT-PCR was used
to analyze mRNA levels of PGC1-α. b Immunoblot of mitochondrial
OXPHOS Complex IV from DRG total extracts of Ctrl and STZ M and F
rats. Representative Western blots are presented above the graph, with
the respective loading control (GAPDH). The densitometry of each
band was analyzed, and the results are expressed as percentage of M
Ctrl. c Total DNA was isolated from non-diabetic Ctrl and STZ rats and
run for quantitative real-time PCR to obtain a relative ratio of mt-CoxII
(a gene coded on the mitochondrial genome) over 36B4 (a gene
coded on nuclear genome), as indicator for relative mt-DNA copy
number. The columns represent the mean ± SEM, n = 6 animals for
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##p < 0.01; ###p < 0.001) followed by Bonferroni post hoc test
(significance: *p < 0.05; **p < 0.01)
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Short-term diabetes does not alter the expression of OPA1
Optic Atrophy Protein 1 (Opa1) is one of the key players
of the fusion process. It is localized in the inner mitochon-
drial membrane, interacting with both MFN1 and 2. Two-
way ANOVA analysis showed no significant effect of
diabetes or sex on OPA1 expression (Fig. 7c).
Neuroactive steroid levels are altered by diabetes in a
sex-dimorphic way
The above results showed a clear sex difference in the
impact of short-term diabetes in the content of motor
proteins and mitochondrial function. These observations
pointed to a possible role of neuroactive steroids. On this
basis, we explored whether neuroactive steroid levels in
the sciatic nerve of control and diabetic male and female
rats were differently affected by short-term diabetes.
We measured the levels of progesterone and its
metabolites (dihydroprogesterone, allopregnanolone,
and isopregnanolone) and testosterone and its metabolites
(dihydrotestosterone, 5α-androstane-3α,17β-diol and 5α-
androstane-3β,17β-diol) as well as 17α-estradiol and 17β-
estradiol by LC-MS/MS in the sciatic nerve. The results
are shown in Table 4. As expected, levels of progesterone
and its metabolites were higher in females than in males
whereas the levels of testosterone and its active me-
tabolite dihydrotestosterone were higher in male than
in female animals. In males, diabetes induced a very
significant decrease in the levels of testosterone and
dihydrotestosterone and a significant increase in the
levels of allopregnanolone. On the contrary, none of
the neuroactive steroids analyzed showed alterations
in its levels in female diabetic animals.
Discussion
Our findings indicate that short-term diabetes alters the
expression of genes involved in mitochondrial function
and dynamics as well as the content of key motor pro-
teins important for axonal transport in the PNS of males
but not in females. Moreover, we showed that early
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by Bonferroni post hoc test (significance: *p< 0.05)
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diabetes is associated with a decrease in the levels of
specific neuroactive steroids in males but not in females,
suggesting that the increased resistance of females to
diabetes-induced axonal transport damage may be re-
lated to the positive effect of female sex steroids on
mitochondria.
Specifically, we showed that short-term diabetes alters
both the mRNA levels and axoplasm content of KIF1A
and KIF5B and axoplasm content of KIF5A and Myosin
Va, but only in male animals. No changes in dynein
levels were detected. Since dynein is involved in retro-
grade transport, this finding suggests that the antero-
grade but not the retrograde transport is impaired in an
early stage of the disease in male animals.
KIF5A is known to be responsible for the transport of
neurofilaments (NF) [31]. NF are affected since the earli-
est stage of the disease contributing to the axonal degen-
eration [32, 33]. The decrease in the expression of
KIF5A in the axoplasm of males may be due to the im-
balance in protein synthesis or axonal transport deficit.
Protein and mRNA levels of KIF5A were not affected by
diabetes in the DRG, suggesting that the local depletion
of KIF5A in the axoplasm is not a consequence of a
change at the transcript level but it might be the result
of a defect in the molecular motor function slowing
down KIF5A mobility along the axon.
In addition to KIF5A, KIF5B protein levels were also
decreased in the isolated axoplasm in males but not in
females. As for KIF5A, no changes were observed for
KIF5B protein levels in the DRG. This result suggests
that also in this case, the decrease of KIF5B might result
from a defect in the molecular motor function. This ob-
servation is consistent with what observed by Baptista
and collaborators [6] who showed that KIF5B protein
immunoreactivity decreased in the axons of hippocam-
pal cell cultures treated for 7 days with glucose. A
previous study in STZ-induced diabetic rats, however,
reported an increase in KIF5B protein content in the sci-
atic nerve of diabetic animals [9]. A possible explanation
for this discrepancy could be the strategy used to meas-
ure protein levels. In the previous study, levels of KIF5B
were determined in total sciatic homogenate using
ELISA method. It is worth remembering that KIF5B is
expressed ubiquitously [34]; thus, measuring KIF5B
levels in a total sciatic nerve homogenate may not pro-
vide accurate estimates of this motor protein in axons.
To avoid confounding results due to the presence of this
protein in Schwann cells [35], we performed our analysis
in the isolated axoplasm.
Besides the decrease of KIF5B protein levels in the axo-
plasm, we found a significant increase in its mRNA levels
in the DRG of diabetic male animals when compared to
controls. An overexpression of KIF5B was also found in
the hippocampal at 2 weeks of diabetes [6]. We can specu-
late that this increased expression might function as a
compensatory mechanism to re-establish the decrease
level of this motor along the axon. Further analysis, how-
ever, will be necessary to support this hypothesis.
Another important molecular motor essential for the
sensory neuronal function is KIF1A. Interestingly, recent
evidence showed that KIF1A, besides its known role in
transporting synaptic vesicles [36], is also involved in the
transport of the NGF receptor TrkA in axons of DRG
neurons. This transport plays an important role in PI3K-
mediated cell survival and sensitization supporting neur-
onal viability [37]. Our findings indicate that KIF1A
mRNA levels are significantly increased in DRG of
diabetic males when compared to controls. In addition, a
significant increase of this motor protein was evident in
the axoplasm of male diabetic animals. Due to the role
of KIF1A in mediating the signaling pathway responsible
for sensory function in the PNS [37], it is tempting to
Table 4 Neuroactive steroids in the sciatic nerve of male and female control and diabetics
Male Female
Ctrl STZ Ctrl STZ
Progesterone 3.17 ± 0.3 3.21 ± 0.5 5.68 ± 0.7 4.00 ± 0.3
Dihydroprogesterone 1.15 ± 0.5 1.92 ± 0.7 17.60 ± 3.6 16.30 ± 3.2
Allopregnanolone 3.28 ± 0.2 7.63 ± 1.7*** 10.50 ± 0.9 10.70 ± 1.4
Isopregnanolone 0.37 ± 0.1 0.27 ± 0.1 16.40 ± 2.2 16.80 ± 4.1
Testosterone 2.59 ± 0.6 0.55 ± 0.4*** 0.42 ± 0.1 0.35 ± 0.1
Dihydrotesterone 12.10 ± 0.8 2.23 ± 0.6*** UDL UDL
5α-Androstane-3α 17β-diol 0.95 ± 0.5 0.31 ± 0.2 0.66 ± 0.3 0.10 ± 0.1
5α-Androstane-3β 17β-diol 5.40 ± 1.3 4.50 ± 0.6 4.21 ± 1.0 5.92 ± 0.6
17α -Estradiol 0.56 ± 0.1 0.63 ± 0.1 0.67 ± 0.1 0.74 ± 0.1
17β -Estradiol 0.43 ± 0.1 0.44 ± 0.1 0.78 ± 0.3 0.60 ± 0.7
Neuroactive steroid levels were evaluated by liquid chromatography tandem mass spectrometry. Data are expressed as pg/mg of tissue ± SEM. The number of
animals utilized was 6. Analysis by Student’s t test ***p < 0.001 vs Ctrl
Ctrl control, STZ diabetics, UDL under detection limit
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speculate that sex-specific alteration of this motor pro-
tein found in diabetic animals may ultimately account
for sexual dimorphism in pain and analgesia observed in
diabetic humans and in diabetes animal models [14, 15].
Diabetes also induced an alteration in Myosin Va in
males but not in females. Myosin Va protein levels were
significantly higher in the axoplasm of male diabetic ani-
mals compared to male controls whereas no changes
were observed either in the protein or in the mRNA
levels in the DRG. Myosin Va has been implicated in a
wide range of cargo transport, supporting multiple func-
tions within neurons [4]. Previous studies showed a
decrease in myosin Va in brain neuronal cell bodies of
STZ-rats at an early stage of diabetes, as well as in
jejunal musculomotor nerve terminals 16 weeks after
induction of diabetes [38, 39]. These finding are in con-
trast with our results. One possibility for this discrep-
ancy may be that diabetes affects the expression and
content of this motor protein in a time- and tissue-
specific way. Importantly, myosin Va can function as a
tether for kinesins preventing their diffusion away from
the microtubule track, enhancing kinesin processivity
[40]. Thus, the increase of myosin Va at an early stage of
diabetes might be interpreted as an attempt to cope with
the diabetes-mediated impairment of axonal transport. In-
deed, it has been demonstrated that myosin can be locally
synthesized in the sciatic nerve following nerve injury [25].
Axonal transport consumes high ATP levels through
translocation of motor proteins [41–43]. Mitochondria are
the site of oxidative phosphorylations (OXPHOS/respira-
tory chain complex I–V) where most of the energy is pro-
duced in the form of ATP derivatives. Previous studies
have shown a reduced activity and protein expression of
the mitochondrial respiratory chain in the DRG of rodents
with type 1 and type 2 diabetes [44–46]. Furthermore,
levels of the respiratory chain complex IV was found to be
significantly reduced in IENF and subpapillary dermal fi-
bers in skin samples of persons with diabetic neuropathy
already at an early stage of the disease, prior to significant
fiber loss [47]. In agreement with these previous reports,
we detected a significant decrease in the expression of
complex IV in the DRG of male diabetic animals. Import-
antly, this alteration was not detected in female rats, indi-
cating that mitochondrial respiratory chain from female
rats is not affected by diabetes in an early stage of the dis-
ease. This feature could be related to the sex differences in
mitochondrial respiratory function. Indeed, female mito-
chondria have higher electron transport chain activity and
ATP production [48, 49]. Moreover, as observed in the
brain of young mice, females have higher NADH-linked
respiration than males [50]. Thus, it is reasonable to
suppose that the greater functional capacities in female
mitochondria might account for the higher resistance to
diabetic insults observed in our study.
PGC-1α is a transcriptional coactivator that co-ordinates
the expression of multiple mitochondrial proteins involved
in mitochondrial biogenesis. It also regulates the expression
of respiratory chain complex I to V [51]. The analysis of the
expression of PGC-1α in DRG revealed a significant effect
of sex with an overall lower level of PGC-1α transcript in
female rats. This is in agreement with previous findings in
the mouse brain [52]. We also found a significant effect of
diabetes. Interestingly, PCG-1α mRNA levels were de-
creased in diabetic males compared with control males. On
the contrary, this effect of diabetes was not detected in
females. A decrease in PGC-1α expression was previously
observed in DRG of rats and mice with type 1 or type 2
diabetes [53]. Moreover, in diabetic mice, knocking down
PGC-1α worsens diabetic neuropathy [27]. In the light of
our data, we propose that the downregulated expression of
PGC-1α in diabetic males may be involved in the decrease
in the levels of the respiratory chain complex IV found in
the same animals. In agreement with the observations
obtained in several cell lines by Li and colleagues [54], we
observed that in male STZ DRG the decrease in the levels
of complex IV secondarily results in a decline of ATP levels.
These effects did not occur in female animals, suggesting
that short-term diabetes alters, only in male animals, the
mitochondrial function.
There is a complex relationship between bioenergetics
and mitochondrial dynamics. Mitochondrial dynamics is
a process used by these organelles to adapt their shapes,
through frequent fusion and fission events, in response
to changes in energy demand and supply [55]. Vincent
and collaborators suggested that mitochondrial fission is
increased in diabetes to meet the greater energetic re-
quirements of a hyperglycemic state [56]. However, since
fission does not require replication of mtDNA, rapid
mitogenesis eventually leads to unhealthy mitochondria
[56]. Alternatively, mitochondria fusion can be activated
in response to mitochondrial stress to dilute mutated
mtDNA and rescue damaged mitochondria via the ac-
quisition of key components from healthy mitochondria
[57]. One of the key regulators of mitochondrial fission
is dynamin-1-like protein (DRP1). Inhibition of DRP1 re-
sults in decreased susceptibility to hyperglycemic dam-
age in DRG neurons [29]. In the present study, we found
a significant increase in the expression of activated
DRP1 in the DRG of diabetic males, suggesting an over-
activity of mitochondrial fission at short-term diabetes. In
addition, the stable mtDNA expression observed here be-
tween control and diabetic animals indicates that fission of
preexisting mitochondria is taking place with no alterations
on mtDNA content, promoting mitochondrial fragmenta-
tion and probably impairing mitochondrial function. On
the other hand, consistently with the results obtained here
for other parameters, diabetes did not induce significant
changes in the expression of DRP1 in females, indicating
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that also for this parameter, females are protected from
diabetes-induced alterations.
Mitofusin 1 and 2 (MFN1 and MFN2) and optic atrophy
protein 1 (OPA1) have a central role in mitochondrial fu-
sion in both rodents and humans [58]. In our study, we
did not find significant changes in OPA1 protein levels in
DRG of diabetic animals. However, the expression of
MFN2 was decreased in the DRG of male diabetic animals
compared to control males. Again, no significant changes
were observed in female animals. Previous works showed
that MFN2 expression is reduced in patients with obesity
or type 2 diabetes as well as in obese Zucker rats, a model
of type 2 diabetes, suggesting that mitochondrial fusion is
an important factor in the pathophysiology of these disor-
ders [59, 60]. Here, we extended these observations
reporting an impairment of this protein in a model of type
1 diabetes.
Interestingly, MFN2 also facilitates the axonal trans-
port of mitochondria binding to kinesin motor proteins
via the adaptor proteins Miro/Milton [30, 61]. Indeed,
MFN2 conditional knockout mice display fragmented
and aggregated mitochondria in dendrites [62]. Finally,
this protein has an essential role in oxidative phosphor-
ylation during mitochondrial respiration [63]. Thus, we
can expect that the decrease of this key regulatory pro-
tein can worsen the neurodegenerative process acting at
different levels: energetic, structural, and functional.
Mitochondrial function and biogenesis are regulated
by sex hormones [64]. For example, estradiol increases
the expression of PGC-1α in mouse female hearts [65]
and enhances the activity of complex IV in rat brain
mitochondria [66]. Estradiol and progesterone are also
able to modulate mitochondrial fusion and fission genes,
stimulating MFN1 and MFN2 expression [67]. We previ-
ously demonstrated in a model of long-term diabetes,
that the levels of neuroactive steroids in PNS are differ-
ently affected by the disease in male and female animals
[18]. Therefore, different levels of neuroactive steroids
may contribute to sex differences in mitochondrial func-
tion of diabetic rats.
On this basis, we evaluated whether short-term diabetes
changes the levels of testosterone and progesterone as well
as their metabolites. We found that, in the sciatic nerve of
male rats, short-term diabetes is associated with a de-
crease of testosterone and dihydrotestosterone. Interest-
ingly, low levels of testosterone in men are associated with
decreased expression of genes involved with energy me-
tabolism and with reduced expression and activity of
mitochondrial respiratory chain [68, 69]. Thus, it could be
hypothesized that, at least in sciatic nerve, androgens may
exert a positive effect on mitochondrial function and bio-
genesis in males. This effect seems not to be related to
changes in androgen receptor, which is expressed in DRG
[70]. Indeed, AR gene expression in DRG male rats is not
affected by short-term diabetes (data not shown). Besides
the decrease of these androgens, we also found an increase
in allopregnanolone. A previous study demonstrated a
protective role of this steroid in apoptosis-induced mito-
chondria release of cytocrome c [71]. We can speculate
that the increase in allopregnanolone might be an attempt
to cope with the diabetes-mediated impairment of mito-
chondria. It is worth noticing, however, that this increase
is transient since the level of this steroid returns to control
values at 3 months of diabetes [18]. On the other hand, no
changes were observed between diabetic and control fe-
male rats. The positive effect of estrogens on mitochon-
drial functional capacities together with the stable levels of
this steroid in diabetic female rats may explain in part why
female mitochondria resulted protected from diabetic in-
sult. Levels of estrogens, however, were not affected by
diabetes also in males. Nevertheless, it is worth consider-
ing that estrogens can affect mitochondrial dynamics in
sex-specific way, resulting in protection for female but not
male mitochondria [67, 72].
Conclusions
Our findings demonstrate that short-term diabetes differ-
entially affects in males and females the levels of specific
neuroactive steroids in the sciatic nerve. In addition, fe-
male mitochondria in the DRG were protected from dia-
betes whereas in the male DRG diabetes induced several
alterations in the expression of proteins involved in mito-
chondrial function and dynamics. Finally, the levels of
molecules involved in anterograde axonal transport were
differentially affected by diabetes in the sciatic nerve of
male and female rats. The preservation in the levels of
neuroactive steroids in diabetic females may contribute to
prevent mitochondrial alterations in these animals. In
turn, proper functionality of mitochondria may preserve
axonal transport in female diabetic rats.
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